|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023324,
umls-concept:C0053373,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0205531,
umls-concept:C0226896,
umls-concept:C0332624,
umls-concept:C0442027,
umls-concept:C1521801,
umls-concept:C1527249,
umls-concept:C1527415
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-7-14
|
|
pubmed:abstractText |
Lentinan (LNT) is an immune adjuvant medicine for advanced gastric cancer in Japan. Recently, an oral formulation of superfine dispersed lentinan (SDL) has become clinically available. To investigate the safety and effectiveness of SDL, a multi center clinical study in patients with advanced colorectal cancer was conducted.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1791-7530
|
|
pubmed:author |
pubmed-author:HazamaShoichiS,
pubmed-author:MatsudaKenjiK,
pubmed-author:NakazawaSaburoS,
pubmed-author:OhashiManabuM,
pubmed-author:OkaMasaakiM,
pubmed-author:SugaTetsuyaT,
pubmed-author:SugaYasuyoY,
pubmed-author:SuzukiMichinariM,
pubmed-author:WatanabeSeijiS,
pubmed-author:YagiMasashiM,
pubmed-author:YamamotoTatsuhitoT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2611-7
|
|
pubmed:meshHeading |
pubmed-meshheading:19596936-Adjuvants, Immunologic,
pubmed-meshheading:19596936-Administration, Oral,
pubmed-meshheading:19596936-Adult,
pubmed-meshheading:19596936-Aged,
pubmed-meshheading:19596936-Aged, 80 and over,
pubmed-meshheading:19596936-Antineoplastic Agents,
pubmed-meshheading:19596936-Colorectal Neoplasms,
pubmed-meshheading:19596936-Female,
pubmed-meshheading:19596936-Humans,
pubmed-meshheading:19596936-Lentinan,
pubmed-meshheading:19596936-Male,
pubmed-meshheading:19596936-Middle Aged,
pubmed-meshheading:19596936-Quality of Life
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
|
|
pubmed:affiliation |
Department of Surgery II, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan. hazama@po.cc.yamaguchi-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
